Myocardial infarction

891,467views

Myocardial infarction

5600

5600

Anatomy of the larynx and trachea
Bones and joints of the thoracic wall
Vessels and nerves of the thoracic wall
Anatomy of the lungs and tracheobronchial tree
Muscles of the thoracic wall
Anatomy of the pleura
Development of the respiratory system
Nasal cavity and larynx histology
Bronchioles and alveoli histology
Trachea and bronchi histology
Respiratory system anatomy and physiology
Ventilation-perfusion ratios and V/Q mismatch
Ventilation
Alveolar surface tension and surfactant
Upper respiratory tract infection
Sinusitis
Retropharyngeal and peritonsillar abscesses
Laryngitis
Bacterial epiglottitis
Anatomy of the pharynx and esophagus
Anatomy of the superior mediastinum
Anatomy of the inferior mediastinum
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Airflow, pressure, and resistance
Breathing cycle and regulation
Lung volumes and capacities
Pulmonary edema
Anatomic and physiologic dead space
Pulmonary shunts
Diffusion-limited and perfusion-limited gas exchange
Alveolar gas equation
Gas exchange in the lungs, blood and tissues
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Pleura and lungs
Otitis media
Eustachian tube dysfunction
Corynebacterium diphtheriae (Diphtheria)
Haemophilus influenzae
Bacterial tracheitis
Pediatric upper airway conditions: Clinical
Rhinovirus
Adenovirus
Moraxella catarrhalis
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Human parainfluenza viruses
Epstein-Barr virus (Infectious mononucleosis)
Influenza virus
Pediatric ear, nose, and throat conditions: Clinical
Alpha 1-antitrypsin deficiency
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Breathing cycle
Allergic rhinitis
Nasopharyngeal carcinoma
Oral cancer
Nasal polyps
Warthin tumor
Sjogren syndrome
Nasal, oral and pharyngeal diseases: Pathology review
Choanal atresia
Sialadenitis
Aphthous ulcers
Sleep apnea
Thoracic outlet syndrome
Neonatal respiratory distress syndrome
Cystic fibrosis
Cystic fibrosis: Clinical
Cystic fibrosis: Pathology review
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Idiopathic pulmonary fibrosis
Sarcoidosis
Hypersensitivity pneumonitis
Obstructive lung diseases: Pathology review
Chronic bronchitis
Emphysema
Asthma
Asthma: Clinical
Bronchiectasis
Type I hypersensitivity
Pharmacodynamics: Desensitization and tolerance
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical
Mycoplasma pneumoniae
Pulmonary changes at high altitude and altitude sickness
Oxygen-hemoglobin dissociation curve
Bronchodilators: Leukotriene antagonists and methylxanthines
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Tuberculosis: Pathology review
Respiratory syncytial virus
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Pancoast tumor
Horner syndrome
Superior vena cava syndrome
Chronic obstructive pulmonary disease (COPD): Clinical
Chlamydia pneumoniae
Coxiella burnetii (Q fever)
Klebsiella pneumoniae
Streptococcus pneumoniae
Pseudomonas aeruginosa
Chronic granulomatous disease
Bordetella pertussis (Whooping cough)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pleural effusion: Clinical
Pleural effusion
Pneumothorax: Clinical
Pneumothorax
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical
Pulmonary hypertension
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Pulmonary embolism
Pulmonary hypoplasia
Congenital diaphragmatic hernia
Mesothelioma
Respiratory distress syndrome: Pathology review
Pulmonary changes during exercise
Pulmonary chemoreceptors and mechanoreceptors
Pulmonary corticosteroids and mast cell inhibitors
Syncope: Clinical
Anatomy of the heart
Anatomy of the coronary circulation
ECG rate and rhythm
ECG normal sinus rhythm
ECG QRS transition
Cardiac conduction system
Normal heart sounds
Vasculitis: Clinical
Aortic aneurysms and dissections: Clinical
Vascular tumors
Aneurysms
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Raynaud phenomenon
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombophlebitis
Lymphedema
Angiosarcomas
Cardiac and vascular tumors: Pathology review
Sturge-Weber syndrome
Vasculitis: Pathology review
Kawasaki disease
Kawasaki disease: Clinical
Mitral valve disease
Tricuspid valve disease
Aortic valve disease
Pulmonary valve disease
Introduction to the cardiovascular system
Development of the cardiovascular system
Fetal circulation
Cardiac muscle histology
Arteriole, venule and capillary histology
Artery and vein histology
Cardiovascular system anatomy and physiology
Coronary circulation
Lymphatic system anatomy and physiology
Blood pressure, blood flow, and resistance
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Resistance to blood flow
Control of blood flow circulation
Microcirculation and Starling forces
Measuring cardiac output (Fick principle)
Frank-Starling relationship
Stroke volume, ejection fraction, and cardiac output
Cardiac afterload
Cardiac preload
Law of Laplace
Cardiac contractility
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Pressure-volume loops
Cardiac work
Changes in pressure-volume loops
Abnormal heart sounds
Action potentials in myocytes
Excitability and refractory periods
Action potentials in pacemaker cells
Cardiac excitation-contraction coupling
Cardiac conduction velocity
ECG basics
ECG intervals
ECG axis
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Transposition of the great vessels
Tetralogy of Fallot
Persistent truncus arteriosus
Total anomalous pulmonary venous return
Hypoplastic left heart syndrome
Patent ductus arteriosus
Coarctation of the aorta
Ventricular septal defect
Atrial septal defect
Human herpesvirus 8 (Kaposi sarcoma)
Lymphangioma
Chronic venous insufficiency
Vasculitis
Behcet's disease
Aortic dissection
Marfan syndrome
Myocarditis
Endocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Cardiac tamponade
Arterial disease
Angina pectoris
Unstable angina
Myocardial infarction
Prinzmetal angina
Hypertension
Hypertensive emergency
Renal artery stenosis
Orthostatic hypotension
Hypotension
Atrial flutter
Atrial fibrillation
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Dyslipidemias: Pathology review
Hypertension: Pathology review
Endocarditis: Pathology review
Pericardial disease: Pathology review
Shock
Shock: Clinical
Shock: Pathology review
Premature atrial contraction
Wolff-Parkinson-White syndrome
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Brugada syndrome
Long QT syndrome and Torsade de pointes
Atrioventricular block
Bundle branch block
Heart failure
Cor pulmonale
Heart failure: Clinical
Heart failure: Pathology review
Positive inotropic medications
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
cGMP mediated smooth muscle vasodilators
Adrenergic antagonists: Beta blockers
Calcium channel blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Ventricular arrhythmias: Pathology review
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Cardiac tumors
Dressler syndrome
Familial hypercholesterolemia
Abetalipoproteinemia
Hypertriglyceridemia
Hyperlipidemia
Pheochromocytoma
Antihistamines for allergies
Mycobacterium avium complex (NORD)
Nocardia
Pneumocystis jirovecii (Pneumocystis pneumonia)
Cryptococcus neoformans
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Blastomycosis
Aspergillus fumigatus

Transcript

Watch video only

According to the world health organization, cardiovascular disease is the leading cause of death worldwide, as well as in the US. Of those, a large proportion are caused by heart attacks, also known as acute myocardial infarctions, or just myocardial infarctions, sometimes just called MI.

The word infarction means that some area of tissue has died due to a lack of blood flow, and therefore a lack of oxygen. “Myo” refers to the muscle, and “cardial” refers to the heart tissue. So with a heart attack, or MI, you have death of heart muscle cells because of a lack in blood flow, a process called necrosis. Now the heart’s main job is to pump blood to your body’s tissues right? Well, the heart also needs blood, and so it also pumps blood to itself, using the coronary circulation. The coronary circulation is this system of small arteries and veins that help keep the heart cells supplied with fresh oxygen. Heart attacks happen when these small arteries become blocked and stop supplying blood to the heart tissue, and if this happens for long enough, heart tissue dies.

Almost all heart attacks are ultimately a result of endothelial cell dysfunction, which relates to anything that irritates or inflames the slippery inner lining of the artery—the tunica intima. One classic irritant are the toxins found in tobacco which float around in the blood and damage these cells. That damage then becomes a site for atherosclerosis, a type of coronary artery disease where deposits of fat, cholesterol, proteins, calcium, and white blood cells build up and start to block blood flow to the heart tissue. This mound of stuff has two parts to it, the soft cheesy-textured interior and the hard outer shell which is called the fibrous cap. Collectively this whole thing’s ominously called plaque. Usually, though, it takes years for plaque to build up, and this slow blockage only partially blocks the coronary arteries, and so even though less blood makes it to heart tissue, there’s still blood. Heart attacks happen when there’s a sudden complete blockage or occlusion of a coronary artery—so let’s see how that can happen. Since these plaques sit right in the lumen of the blood vessel, they’re constantly being stressed by mechanical forces from blood flow, and interestingly it’s often the smaller plaques with softer caps rather than the larger ones with harder caps that are especially prone to break or get ripped off. Once that happens the inner cheesy filling which remember is this mix of fat, cholesterol, proteins, calcium, and white blood cells, is thrombogenic, and this means that it tends to form clots very quickly. So platelets, or blood-clotting components in the blood, flow by and get excited; and they adhere to the exposed cheesy material. In addition to piling up, the platelets also release chemicals that enhance the clotting process. Now this happens super fast, think about how quickly a small cut stops bleeding, that’s a very similar process—it happens in a matter of minutes, right? And now that coronary artery is fully occluded.

So now let’s change views a bit, If we take a slice of the heart like this, this side being posterior, or back, and this being anterior, or the front, with the left and right ventricles here, and then we have the three most commonly blocked arteries—the left anterior descending, or LAD which supplies blood to the anterior wall and septum of the left ventricle which accounts for 40-50% of cases, the right coronary artery, or the RCA which covers the posterior wall, septum and papillary muscles of the left ventricle—accounts for about 30-40% of cases, and finally, the left circumflex artery, or LCX which supplies to the lateral wall of the left ventricle —about 15-20% of cases. Notice that the majority of these areas supply the left ventricle—most heart attacks therefore involve the left ventricle, where the right ventricle and both atria—the upper chamber—aren’t as often affected.

Each of these areas is called the artery’s zone of perfusion. And, if we take a closer look at one of these zones, we’ll see that basically you’ve got the endocardium, which is the smooth membrane on the inside of the heart, and then the myocardium, all the heart muscle, and then, the epicardium, the outer surface of the heart, which is where the coronary arteries live. Let’s say the LAD gets blocked, the area of perfusion is now at serious risk, and within about a minute, the muscle cells in this zone don’t see enough oxygen and become ischemic, and the muscle layer’s ability to contract is severely reduced. This initial stage is extremely sensitive, since the ischemic damage to cells in the perfusion zone is potentially reversible. After about 20-40 minutes, though, damage starts to become irreversible and the cells start to die, and this zone changes to a zone of necrosis, or dead tissue. Once lost, these cells will never return or regrow—that’s why quickly identifying and treating an MI quickly is super important.

The first area affected is the inner third of the myocardium, since it’s farthest from the coronary artery and the last area to receive blood, and it’s subject to higher pressures from inside the heart. If the blockage suddenly lyses or breaks down and blood flow returns, sometimes patients’ damage will be limited to the inner third, and this would be called a subendocardial infarct. An ECG, or electrocardiogram, done at this point typically shows an ST-segment depression, or in other words, it doesn’t show ST segment elevation, so sometimes we call this an NSTEMI which stands for non-ST elevation myocardial infarction.Other causes of this sort of subendocardial infarcts would be severe atherosclerosis and hypotension—anything that ultimately leads to poor perfusion of the heart tissue. After about 3 to 6 hours, though, the zone of necrosis extends through the entire wall thickness, called a transmural infarct, which this time shows up as ST-segment elevation on ECG, which is why they’re sometimes called STEMIs, or ST elevation myocardial infarctions. So the difference between NSTEMIs and STEMIs is that NSTEMIs don’t have ST-segment elevation, and these are caused by partial infarct of the wall, whereas STEMIs have ST-segment elevation and involve the whole wall thickness.

Patients that have an MI will most commonly have severe and crushing chest pain or pressure, that might radiate up to the left arm or jaw, they might have diaphoresis or sweating, nausea, fatigue, and dyspnea. All of these are either a direct result of an end-organ like the heart or the brain not getting enough perfusion—so think chest pain and dizziness. Or from the sympathetic response from the body to help the heart work harder and preserve blood pressure—so think sweating and clammy skin. Many people also have referred pain where the nerves in the heart are irritated, but that pain can be felt in the jaw, shoulder, arm, or back instead.

Key Takeaways

Myocardial infarction (MI), also known as a heart attack, occurs when the blood supply to part of the heart muscle is blocked. This is usually caused by a buildup of fatty deposits in the lining of an artery that supplies blood to the heart, a process called atherosclerosis. Symptoms of MI include crushing chest pain or pressure that might radiate up to the left arm or jaw, sweating, nausea, and dyspnea. Treatment of MI includes re-establishing blood flow using medications, angioplasty, or percutaneous coronary intervention.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison’s principles of internal medicine" McGraw Hill / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Coronary Plaque Disruption" Circulation (1995)
  6. "The role of oxidants and free radicals in reperfusion injury" Cardiovascular Research (2006)